🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#mdpijcm #SpecialIssue "Transcatheter Mitral and Tricuspid Valve Repair: Advances and Challenges" is open for submissions mdpi.com/journal/jcm/sp… Submission deadline: 15 August 2022 #MitralRegurgitation #TricuspidRegurgitation

‘Primary’ percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime? academic.oup.com/eurheartj/adva… MIЯVΛƬ #IC Mamas A. Mamas Pascal Meier,MD Ankur Kalra Less-Is-More Cardiologist Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @ajaykirtane Dr Roxana Mehran Dr. Deepak L. Bhatt Aaysha Cader

Our study comparing Conservative, Surgical and Percutaneous treatment following MI was recently published in the EHJ. Editorial by D. Messika-Zeitoun, B. Hibbert and V. Chan published at the same issue calls for RCT: doi.org/10.1093/eurhea… I Agree!

EHJ Issue 43-7 - here is our video announcement! Our new EHJ issue provides a comprehensive update on valvular heart disease - from mechanisms to Guidelines: academic.oup.com/eurheartj/arti… #CardioTwitter European Society of Cardiology Journals European Society of Cardiology

Early intervention may mitigate the poor prognosis associated with conservative therapy in patients with post-MI MR. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction academic.oup.com/eurheartj/arti…

Despite similar procedural success, percutaneous mitral valve repair for post-MI mitral regurgitation was associated with lower in-hospital and 1-year mortality vs. surgical mitral valve repair or replacement Dan Haberman #EHJ #CardioTwitter healio.com/news/cardiac-v…

Join us at 7:30 AM ET Wednesday for cath conference. Kashish Goel will discuss OA of LM Bifurcation Lesion w/ microcatheter protection of nonatherectomy wire, and Dan Haberman will discuss treatment for MR Post-AMI. Email [email protected] for a registration link.

Randomized trials are required to confirm our findings. Still TEER seems to be safe and effective in this population

New US technique using microconvex probe can enhance venous angle - innominate vein visualization to support bedside CV procedures! Honored to develop and serve as PI. WhiteSwell Ltd. William Abraham Echocardiography @POCUS_Society authors.elsevier.com/a/1fl3T3BS3sTP…

Presenting results of TEER in Acute mitral regurgitation following acute myocardial infarction, PMV vs. Functional at PCR London valves, tomorrow. #PCRLV #PCRPresenter

Presenting TV annuloplasty with Cardioband for patient with torrential TR and extreme coaptation gap (vc=22mm) in “my crazy Mital / Tricuspid” session, ICI 2022, TLV, Israel. And what a panel! francesco maisano Paul Fefer Mony Shuvy

I had the honor to present and discuss a case of vivTAVR with 23mm Evolut FX+ in under-expanded 20 mm Sapien 3 requiring leaflet modification achieved with UNICORN technique. #TCT2024 #TAVR MedStar Washington

In our IREMMI registry (post-AMI significant MR), we found high procedural success (~90%) with acute M-TEER for both PMR and SMR. However, clinical outcomes were worse with PMR. Still, M-TEER may serve as a bridge or salvage therapy for post-AMI MR. bit.ly/4jfF4Sy

When closure becomes complication: 7 cases of Perclose-induced CFA occlusion post-TAVR managed percutaneously with cutting balloon angioplasty. Benchtop model confirms mechanism. No surgery. No reintervention. 🧠💡 🔗 DOI: 10.1002/ccd.31598 #TAVR #VCD #CardioTwitter